7 Ohmz 7-Hydroxy Sustained Formula 28mg
The 7 OHMZ 7-Hydroxy Sustained Formula 28mg is a high-potency tablet product engineered for adult retail environments such as smoke shops and specialty extract-focused stores. Each tablet contains 28 mg of 7-hydroxymitragynine, a concentrated alkaloid derived from Mitragyna speciosa, formulated using a sustained-release delivery system designed to provide a gradual and extended experience rather than a rapid onset. This advanced tablet format supports consistent dosing, controlled release, and clean handling, making it ideal for wholesale distribution and structured retail merchandising.
The sustained-release formulation differentiates this product from standard fast-acting extracts by offering a more stable, long-lasting effect profile, reducing the need for frequent re-dosing throughout the day. Its compact, pre-dosed tablet format allows for efficient inventory management, discreet portability, and convenient grab-and-go placement in high-traffic retail areas. Positioned within the premium 7-hydroxy extract category, it appeals primarily to experienced consumers seeking extended-duration performance and consistency in a single dose format.
As demand continues to grow for advanced alkaloid formulations and sustained-release extract products, this SKU provides retailers with a high-margin, differentiated offering that stands out from traditional kratom powders, capsules, and rapid-release tablets. The 28 mg strength combined with controlled-release technology supports repeat purchasing behavior, strong shelf presence, and integration into wholesale assortments focused on high-potency botanical extracts.
WARNING
• 21+ only — adult use only
• High-potency extract product
• Keep out of reach of children and pets
• For retail sale and display only
• Follow local and state regulations
NOTE: Products containing kratom or concentrated 7-hydroxymitragynine are not evaluated or approved by the FDA and may carry significant health risks. 7-hydroxymitragynine is a biologically active compound with strong activity at opioid receptors and substantially higher potency compared to mitragynine. These products may be restricted or regulated in certain jurisdictions, and retailers and consumers are responsible for complying with all applicable laws and regulations.